Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Tylenol Ad Claim For Aspirin Users Should Not Imply NSAID Inferiority – NAD

This article was originally published in The Tan Sheet

Executive Summary

An ad touting Extra Strength Tylenol as "doctor recommended" for patients on a low-dose aspirin regimen should be modified to exclude inferences that ibuprofen has a deleterious effect on aspirin's cardiovascular benefits, according to the National Advertising Division

You may also be interested in...

McNeil Campaign Advocates Tylenol For Low-Dose Aspirin Users

McNeil Consumer & Specialty Pharmaceuticals is running an ad campaign leveraging research indicating a potential risk in concomitant aspirin and nonsteroidal anti-inflammatory drug use

Bayer Ad Cites NSAID Interference With Aspirin Heart Benefits

Bayer is cautioning consumers against the use of non-steroidal anti-inflammatory drugs in conjunction with aspirin use for heart health in a recently launched television ad campaign

Aspirin MI Prevention Benefits May Be Inhibited By Regular NSAID Use

Regular use of non-steroidal anti-inflammatory drugs may lessen the benefits of aspirin in reducing risk of myocardial infarction, a study recently published in Circulation says

Related Content





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts